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Background. It is recognised that traditional linen curtains are fomites for infectious 
disease in healthcare environments, to which it is likely that these curtains contribute 
to the astronomical cost of healthcare associated infections (HAIs) every year. 
Therefore, to address this issue antimicrobial textiles have been developed. These 
textiles come embedded with a variety of different antimicrobial polymers. The way in 
which these antimicrobial polymers are incorporated into the textile differs depending 
upon the type of textile used. The antimicrobial textiles have to pass industry tests, 
these comparative tests are designed to show significant reductions in microbial 
loads compared to standard fabrics.  
This article aims to review the evidence of the effectiveness of antimicrobial textiles 
in reducing disease transmission in a clinical setting and how this is achieved.  
Methodology. Google Scholar, Pubmed, National Centre for Biotechnology 
Information (NCBI) and Springer Link were searched for publications concerning the 
survival and transmission of pathogenic microorganisms on antimicrobial textiles 
compared to linen or disposable alternatives.  
Results. Many studies specify that there is a significant reduction in the survival of 
microbes on antimicrobial textiles. This reduction in survival was very dependent on 
the type and combination of antimicrobial polymers being used. It has been 
concluded that when in combination the reduction of microbial survival was 
significant for use in a clinical setting, versus insignificant when a single antimicrobial 
polymer is used. Studies investigating the use of various metal nanoparticles in 
combination with antimicrobial polymers concluded that depending on their shape 
and size they will have a dramatic effect on microbial survival and increase the time 
to first contamination. Emerging studies have illustrated that the industry tests 
require additional parameters to ensure that the antimicrobial curtains are to be 
effective in a clinical setting.  
Other studies demonstrate unsuccessful reductions of microbes via industrial 
laundering of linen curtains, resulting in rehanging of contaminated curtains.  
Conclusions. There is a significant need to further test the effectiveness of 
antimicrobial textiles to see whether they successfully reduce microbial carriage. 
This will be achieved by focusing on the modes of transmission. In addition, 
healthcare protocols and studies for laundering linen curtains highlights that it is an 
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outdated method for infection control. bThis is because of inadequate and varying 
changing times. Investigations have highlighted that implementing hospital curtains 
can alleviate costs additional associated with changing and laundering curtains 




It is not a new concept that soft medical fabrics have huge potential to transmit 
disease throughout hospitals (Pinon et al., 2013; Fijan et al., 2007; Kramer et al., 
2006; Trillis et al., 2008; Ohl et al., 2012).  One of the many soft fabrics used in 
hospitals that carry pathogenic microbes are privacy curtains. Privacy curtains were 
first installed into UK hospitals in the 1960s and they were designed to give patients 
more privacy and to help prevent the spread of disease (Accord Curtains, 2015). 
However, it is now known that they are a potential fomite for the spread of 
pathogenic hospital acquired infections (HAIs). Considering 39.5% of HAIs are multi-
drug resistance organisms (MDROs), such as methicillin resistant Staphylococcus 
aureus (MRSA), vancomycin resistant Enterococci (VRE) and Clostridium difficile 
spores, this poses a major problem for infection management in a clinical setting 
(Cornejo-Juárez et al., 2017; Ohl et al., 2012; Woodland et al., 2010; Fijan et al., 
2007; Pinon et al., 2013).  
 
Therefore, the solution is to replace traditional curtains with antimicrobial-embedded 
curtains. These antimicrobial curtains can be either coated, embedded with, or have 
woven into the textile, a variety of antimicrobial polymers. This can consist of metals 
such as silver, copper, and zinc, which can be in combination with substances such 
as quaternary ammonium compounds (QACs).  
For these curtains to be deemed viable in a clinical setting they are required to pass 
‘specified industry standards’ through testing. These comparative tests follow defined 
protocols to show the antimicrobial curtains show a significant reduction in microbial 
count on the curtains compared to traditional curtains. However, these antimicrobial 
textiles often fall into a grey area when tested, as it requires multiple different test 
methods to give conclusive results. These approaches include the 2011 update to 
the ‘International Standard’ 22196 (ISO) on “the measurement of antibacterial activity 
on plastics and other non-porous surfaces” (ISO, 2011) which outlines a comparative 
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method for testing antimicrobial surfaces to ensure their antimicrobial efficacy 
against an untreated sample of the same material.  
Another comparative test used is ISO20743 which is titled the “determination of 
antibacterial activity of textile products” and is used to show the difference in 
bacterial levels which survive the test versus the initial concentration applied (ISO, 
2013).  
Finally, the American Association of Textile Chemists and Colourist (AATCC) TM100 
test which is the “Test Method for Antibacterial Finishes on Textile Materials: 
Assessment of,” which is a quantitative procedure to evaluate the degree of 
antibacterial activity (AATCC, 2021).  
 
Hence the significance of any given study comes in the form of resolvable issues. 
Firstly, the ‘industry standard’ tests may show significant reductions in the level of 
microbes present, however, this is not representative of the environmental conditions 
that the textiles will encounter in a clinical setting and therefore the textile may not be 
effective enough in reducing microbial load under these conditions. Another issue is 
the combination of polymers and the antimicrobials used, as some combinations 
may lack efficacy in real world settings, and therefore finding the most effective 
combination is essential.  
 
These issues will be analysed and explained throughout the four chapters of the 
review. The first chapter consists of an outline of different methodologies used for 
challenge testing microbial loads on soft medical fabrics. Secondly there is analysis 
of the current successful polymers which are embedded into the antimicrobial 
curtains. Thirdly a review of data on the efficacy of using treated medical fabrics to 
show a reduction of disease transmission, with the addition of a cost-benefit analysis 
for using antimicrobial curtains. Finally, suggestions are made on a novel approach 
for challenge testing treated and untreated medical fabrics to produce a replicable 
methodology for testing the efficacy of current and future antimicrobial soft fabrics.  
 
The aims of the study will all be achieved via meta-analysis of the literature, allowing 
for reflection and conclusion on aspects such as whether using antimicrobial textiles 
are beneficial in reducing disease transmission in hospitals and if they are cost 
effective for hospitals. In addition, the identification of the effectiveness of 
 6 
antimicrobials to control microbial load, irrespective of the way the microbes get onto 
the curtain. Conclusions will be drawn regarding the polymer combination which 
most likely to have the highest efficacy in reducing microbial loads on the 
antimicrobial textiles. Another aspect will focus on the industry standard tests to 
show which are most effective in testing the antimicrobial textiles compared to a 
clinical setting and if these tests require additions to increase their efficacy. 
Furthermore, to conclude whether challenge testing antimicrobial surfaces against 
different concentrations of microbes may highlight an increased need for 
antimicrobial fabrics and therefore instigate a change in hygiene policy for certain 
hospitals/organisations. 
 





The healthcare sector is constantly evolving and due to the emphasis placed on 
infection control by organisations such as the NHS and NICE, strategies to reduce 
cross contamination from soft fabrics have been successfully implemented. An 
example of such a strategy is ‘bare below the elbow’. This approach, including 
shortening the sleeves of healthcare workers, emphasises rigorous maintenance of 
hand hygiene and recognises the likelihood of uniform contamination as a cause of 
infection transmission between healthcare workers and patients (NHS, 2021). This 
policy is yet to be backed with supporting evidence, however, prior investigations 
supporting ‘hot spots’ of bacteria around jewellery and the cuff of long sleeves 
concludes that by removing these there will be a reduction bacterial contamination 
(Trick et al., 2003; Treakle et al., 2009). Other investigations have concluded that 
when doctors ‘white coats’ are challenge tested with varying pathogenic microbes, 
they are a reservoir for disease transmission between healthcare workers and 
patients (Hamid et al., 2016). This difference between specifically white coats and 
other medical clothing is due to the current lack of laundering the white coats, 
however textiles such as scrubs are more routinely laundered (NHS, 2021).  
 
 7 
There is a key feature of many clinical settings that have been neglected with 
respect to infection control, despite the wealth of evidence to support the risk of 
contamination: privacy curtains (Woodland et al., 2010; Ohl et al., 2012; Owen and 
Laird., 2020; Carraro et al., 2020). This contamination includes identification of 
curtains as a source of MRDOs (Cornejo-Juárez et al., 2017). This issue requires 
further scrutiny, as HAIs, represent a significant expenditure for organisations such 
as the NHS, which spent an estimated £2.1 billion in 2016/2017 due to their 
deleterious effect on patient outcomes (Guest et al., 2020).  This cost could be 
alleviated or decreased by implementing antimicrobial textiles into the clinical setting, 
illustrated in Tables 1 and 2. However it remains to be determined if antimicrobial 
curtains are a viable solution to reduce disease transmission.  
 





Comparison of costs ($) associated with the use of antimicrobial curtains and 
standard curtains in an 8-Bed cohort cubicle of an acute-care medical ward over a 6-
month period. (Table reproduced from Luk et al., 2019) 
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Table 2: Table illustrating cost benefit of antimicrobial curtain versus a standard 
curtain 
Cost associated with changing ICU curtains over a 6-month period. (Table 
reproduced from Kotsanas et al., 2014) 
 
 
1.2 Hand/touch transmission  
 
There is a significant body of work outlining different standards for hand hygiene 
within hospitals (World Health Organization, 2009). Hand transmission between 
healthcare workers, patients, and visitors may represent the largest deposit of 
pathogens onto fabrics, in terms of number of cells/virions, particularly in high “touch 
traffic” areas. 
For example, on a curtain healthcare professionals, patients and visitors will likely 
touch the same part of the curtain to draw it back each time, increasing the 
probability of contamination (Neely and Maley., 2000; Woodland et al., 2010; Sridhar 
et al., 2016; Owen and Laird., 2020). This concentrated location is repeatedly 
observed in many clinical studies investigating microbial loads on hospital curtains 
which all report taking samples from specific heights of the curtain (Woodland et al., 
2010; Ohl et al., 2012; Schweizer et al., 2012).  
 
1.3 Aerosol transmission 
 
Pathogens are able to spread as particles or droplets in the air (Flügge, 1897). This 
can come in a variety of human secretions including, exhalation via the nose or 
mouth, vomiting and diarrhoea (Eames et al., 2009). These particles/droplets are 
capable of carrying bacteria and viruses acting as a medium to enable transmission 
of infectious disease. The size of the droplet and the humidity of the environment 
have been shown to affect the distance in which droplets can travel. It was 
concluded that the medium-sized droplets (60 μm) are the most affected by humidity, 
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compared to the small and large droplet sizes. This is because small droplets begin 
to evaporate upon release, and larger droplets fall to the floor, therefore the medium 
droplets are able to move further with increased humidity (Lui et al., 2017). 
Precautions to prevent droplet infection transmission can be made such as wearing 
full personal protective equipment (PPE) and regular sanitation of all surfaces (NHS, 
2021). However, typical linen privacy curtains are a limiting factor with their 
replacement time varying and evidence to show survival of pathogens after 
laundering, which will be discussed later in the review (Riley et al., 2017; NHS, 
2021). Therefore, there is a significance in simulating aerosol transmission in this 
study. By observing aerosol transmission, the study will create a variety of factors 
replicable to a clinical setting, which will give conclusive data on the efficacy of the 
antimicrobial textiles.  
Aerosol transmission in a laboratory setting can be achieved by using a nebuliser 
(May, 1973). One advantage of using a nebuliser is that known concentrations of 
inoculum can be prepared and placed inside the nebuliser to give an even and 
replicable coverage of organism over the fabric, recreating a clinical setting (Turgeon 
et al., 2014). Variability between brands of nebuliser has been discussed by Turgeon 
et al. (2014) using four different brands of nebuliser to ensure supporting data was 
viable.  
  
Chapter 2: Incorporation of polymers into antimicrobial textiles and potential 





Incorporating polymers into textiles is a relatively new concept, with products utilising 
quaternary compounds and silver nanoparticles as the antimicrobial agents 
dominating the market. The leading manufacturers of these products are Marlux 
Medical, Endurocide, Hygenica and Interweave. All these companies produce 
antimicrobial curtains for use in a clinical setting, with each brand containing varying 
concentrations of antimicrobial metals in combinations with other patented 
antimicrobials. This chapter will review the antimicrobial mechanisms and 
applications of these commonly used antimicrobials via analysis of the literature. 
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This will highlight the link between structure and function of these antimicrobial 
polymers. In addition, this chapter of the review will include analysis of the reported 
sporicidal properties of these novel medical textiles.  
 
2.2 Silver, a microbial additive for coatings textiles: 
 
Due to its low toxicity to humans (Clement and Jarrett, 1994) silver can safely be 
used as an additive to give textiles a long-lasting efficacy against pathogenic activity, 
making silver a popular additive to medical textiles (Modjarrad and Ednesajjad, 
2013). Silver is an established antimicrobial with activity against bacteria, fungi and 
yeast (Moyer et al., 1965; Fox and Modak, 1974). The mechanisms by which silver 
targets microbes are diverse and very dependent on which form silver is being 
utilised (Rai et al., 2009).  
 
One of these forms includes metallic silver, which reacts with the fluid from wounds. 
The silver becomes ionised, facilitating binding to bacterial cell walls and nuclear 
membranes resulting in membrane and cell wall disruption, lysis and cell death. In 
this metallic form silver can also bind to bacterial DNA and RNA denaturing the 
polynucleotides and therefore inhibiting replication and protein synthesis (Lansdown, 
2002; Castellano et al., 2007). However, metallic silver has weak antimicrobial 
activity and deteriorates rapidly. This is because silver is very easily adsorbed by 
proteins which will reduce its effectiveness before it can interact with bacterial cell 
walls, membranes, or polynucleotides (Castellano et al., 2007; Rai et al., 2009).   
 
Another antimicrobial preparation of silver is silver sulfadiazine (AgSD). With a 
chemical formula of C10H9AgN4O2S, this complex organic structure is a 
sulphonamide-based topical agent with both antibacterial and antifungal activity.  
 
The mechanism of action involves interactions with sodium chloride-contained in 
body fluids, which induces the slow release of silver ions into the wound area. The 
now ionised silver atoms catalyse the disruption of disulphide bonds, causing 
changes in protein structure, and can also disrupt the active sites of thiol-containing 
enzymes. Another antimicrobial mechanism of AgSD involves binding to the DNA, 
specifically to all the base pairs in the double helix, therefore inhibiting transcription 
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(Rosenkranz and Rosenkranz, 1972; McDonnell and Russell, 1999). AgSD is also a 
competitive inhibitor of para-aminobenzoic acid (PABA), which promotes the 
degradation of serotonin, which can result in fibrotic changes, meaning there will be 
no formation of scar tissue (PubChem, 2021).  The mechanism of AgSD and PABA 
is via inhibition of bacterial dihydropteroate synthase which will result in the 
disruption of folic acid metabolism and therefore DNA synthesis (Sandmann et al., 
1974; Bult and Plug, 1984). AgSD does not affect human cells is because of the 
inability to penetrate the surface of the epidermal layer, meaning AgSD will only 
specifically bind to the DNA of the microbe to perform its mechanism of action 
(Gallagher et al., 2007). AgSD is used primarily used in the treatment of burn 
wounds (Fox and Modak, 1974; Atiyeh et al., 2007) but is associated with a number 
of side effects that may make it unappealing for clinical use, including severe allergic 
reactions, which are uncommon but well characterised (Fuller, 2009).  
 
Silver nanoparticles are a much more modern approach to using silver in the medical 
industry. The nanoparticles are extremely effective antimicrobial agents due to their 
large surface area, facilitating better contact with microorganisms (Durán et al., 
2016; Liao et al., 2019). This allows the nanoparticles to attach to the cell 
membrane, and hence penetrate inside the bacterial cell. The silver then attacks the 
respiratory enzymes, reducing ATP availability, therefore inhibiting cell division, 
resulting in cell death (Kazachenko et al., 2000) (Fig. 1).  
Size and shape of silver nanoparticles has a drastic effect on their antimicrobial 
efficacy, with supporting evidence showing that a triangular shaped nanoparticle is 
far superior to a rod or spherical shaped nanoparticles (Morones et al., 2005; Gong 
et al., 2007) (Fig. 2).  
The success of silver in the medical textile industry can also be partly attributed to its 
binding properties to polyester nonwoven fabrics (Yeo and Jeong, 2003). 
 







Silver nanoparticles have been seen to migrate and bind to microbes causing 
damage to proteins, genetic material and membranes, which leads to cell death. This 
is achieved via a direct transfer of silver ions from the oxidised silver nanoparticles to 
the microbe on the surface, causing varying damage to the microbe, resulting in 
lysis.(Diagram reproduced from Knetsch, and Koole, 2011). 
 
 





Nanoscale materials come in many forms, including nanolayers, nanotubes, and 
nanoparticles. The nanoparticles come in a variety of shapes including: circular, 
square, pseudohexagonal and flower shaped. (Diagram reproduced from Sun et al., 
2018). 
 
2.3 Quaternary ammonium compounds: 
 
Quaternary ammonium compounds (QACs) are at the interface of organic and 
inorganic chemistry (Fig. 3), due to their unique physiochemical properties (Bureš, 
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2019). QACs are very stable, and are relatively unaffected by changes in pH, 
remaining effective for long periods of time (Nayak and Padhve, 2014).  
QACs display antimicrobial activity against a large range of pathogens, including 
vegetative bacteria, yeast, viruses, algae and fungi. However, QACs have been 
shown to be ineffective against bacterial spores, mycobacteria and hydrophilic 
viruses (Ravikumar et al., 2006; Hegstad et al., 2010; Fredell, 2019).  
 
The antimicrobial activity of QACs is largely based on their cationic and surfactant 
characteristics (Gilbert and Moore, 2005; Bureš, 2019). In the form of a surfactant 
QACs contain a positively charged and hydrophilic head alongside a hydrophobic tail 
(Fig. 4).  
The positively charged QAC will bind to the negatively charged microbe, forming a 
surfactant-microbe complex. This disrupts the cell membrane function and protein 
activity (Gilbert and Moore, 2005).  
Similarly, QACs can disrupt bacterial DNA, meaning the cells can no longer replicate 
(Marini et al., 2007).  
 





Fig 3. A: QAC only has antimicrobial properties if the akyl chain (R2) contains 
between 4-18 carbon atoms B: Polymers containing tertiary amino groups, such as 
poly-(dimethylaminoethyl methacrylate), can be modified (e.g. quaternied) by specific 
functional halides. (Diagram reproduced from Knetsch, and Koole, 2011). 
 


















Fig. 4 Illustration highlights key aspects of the QAC-derived cationic surfactant 
structure showing the long tail hydrophilic tail and N+ hydrophobic head. 23-29 are 
different structures of the cationic surfactant QAC. (Diagram reproduced from Bureš, 
2019). 
 
The antimicrobial activity of QACs is dependent on the length of the alkyl chain (Fig. 
4), if a long hydrocarbon chain is bonded to the cationic ammonium, penetration of 
the hydrophobic group on the organism will allow the alkylammonium group to 
physically interrupt all cell functions (Simoncic and Tomsic, 2010).  
These factors contribute to the widespread use of QACs, making them a very strong 
candidate for incorporation into antimicrobial textiles (Nohr et al., 1994; 
Thorsteinsson et al., 2003).  
 
One of the limitations associated with QACs is that they leak from the textile to which 
they have been applied. This is because there are no functional groups in the 
structure which allow for prolonged binding to the fibres of the textile. This results in 
a gradual decrease in concentration, eventually falling below the minimum inhibitory 
concentration (MIC), meaning that QAC-incorporated textiles would lose their 
antimicrobial properties over time (Caillier et al., 2009). However, this leaking effect 
can be combatted with sol-gel technology, using mixtures of colloidal solutions such 
as tetra-alkoxysilane (Si(OR)4) combined with QACs which increases their stability 
due to cross linking polymerisation. The sol-gel technology is also used to enhance 
the retention of heavy-metal ions (Zimmermann et al., 2001; Wang and Wang, 
2009). These factors allow for the QACs and other antimicrobial polymers to become 
better incorporated into the fabrics.  
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2.4 Sporicidal properties 
 
Fungi are multicellular organisms that form a network of branching filaments called 
hyphae. Spores are produced from the ends of these hyphae as a strategy of 
asexual reproduction. Hyphae typically grow together across and above a surface 
forming a compact, macroscopically visible tuft called a mycelium. The spores at the 
end of the hyphae are released and spread via wind, water or animals (Madigan et 
al., 2015).  
 
Fungal spores also have a thigmotactic response, meaning an explosive release of 
spores due to a stimulus or touch, which will enable spores to be released into the 
environment, resulting in the spores being able to adhere to surfaces, such as 
textiles (Jones, 1994; Lamprea et al., 2008).   
 
Fungal spores require moisture for germination/adhesion. It is therefore important to 
imbue medical textiles with a compound that increases their hydrophobicity, in order 
to render them water repellent and therefore resistant/hostile to fungal growth. 
Hydrophobicity is achieved by providing hierarchical micro- and nano-scale rough 
structures on the fabric surface (Fig 5.) (Wang et al., 2019).  
Zinc oxide (ZnO) nanoparticles are used as an anti-mildew additive due to their 
antifungal and antibacterial properties. These properties are enhanced when in 
combination with silver nanoparticles and other antibacterial components (Kotsanas 
et al., 2014; Gao et al., 2019).  
 
Figure 5: Scanning electron microscope (SEM) photos of polyethylene terephthalate 
(PET) after γ-methacryloxypropyl trimethoxysilan (MAPS) radiation, ZnO 









Fig 5. Surface morphologies of PET textile analysed under SEM. Fig. 5a and b show 
roughness due to radiation graft polymerisation chains which covered the textile 
resulting in the surface PET-g-PMAPS. Fig. 5c illustrates the result of in situ 
mineralisation treatment, forming a ZnO layer on the surface of the PET-g-PMAPS.  
Fig. 5d and 5f are images of the PET-g-PMAPS/ZnO surface after annealing at 
122oC. Fig. 5e is a transition electron microscopy image (TEM), which illustrates fig. 
5c at higher microscopy, to show that the ZnO nanoparticles have uniformly covered 
the rugged PET-g-PMAPS surface. Fig. 5e includes the confirmation of nanoparticle 
size in fig. 5e of approximately 150nm, of which these nanoparticles have formed a 
film over the material.  
 
ZnO nanoparticles of less than 100nm are reported to have noticeably stronger 
antimicrobial activities than nanoparticles larger than 100nm. In addition, the 
antifungal properties of ZnO are distinctively more effective when in combination with 
other antibacterial such as silver nanoparticles (Singh and Nanda, 2013). 
ZnO is utilised primarily for its prevention of mycotoxin synthesis, which will inhibit 
the production of any spores. Mycotoxins are toxic chemicals present on spores and 
small fragments of the mould fruiting body which can be released into the air; 
 17 
therefore, inhibition of mycotoxin synthesis will stop the formation of spores meaning 
they will never be present to transmit (Betina, 1989).  
 
The shape of the ZnO nanoparticles also effects their efficacy, with flower shaped 
ZnO (Fig. 2) giving the strongest antifungal properties (Hui et al., 2016; Sun et al., 
2018).  
 






Microbial growth on medical textiles is a well-known and documented mode of 
transmission for microbial contamination (Woodland et al., 2010; Ohl et al., 2012; 
Owen and Laird, 2020). Laundering fabrics has been the general option when 
attempting to reduce the levels of microbial contamination on textiles (Bienert et al., 
2006; Hellickson and Owens, 2007; Fijan et al., 2007; Nordstrom et al., 2012; 
Honisch et al., 2014). However, in recent years using disposable and antimicrobial 
textiles has become more prevalent to reduce disease transmission in a clinical 
setting (Boyken and Diekema, 2012; Luk et al., 2019; Wilson et al., 2020).  
The increased use of antimicrobial textiles has arisen from investigations of microbial 
survival on untreated medical textiles, with data showing survival of a plethora of 
organisms, even some after laundering (Neely, 2000; Honisch et al., 2014; Fijan et 
al., 2017; Riley et al., 2017). This chapter will review data that both supports and 
opposes the use of antimicrobial textiles to try and conclude whether there is a 
significant grounding for their use. The supporting chapter will include a cost-benefit 
analysis comparing to linen laundering protocols.  
 
 
3.2 Supporting use of antimicrobial curtains 
 
Firstly, randomised investigations involving antimicrobial privacy curtains have been 
carried out which concluded that there were significant reductions in microbial loads 
 18 
when antimicrobial curtains were used compared to that of linen curtains (Boyken 
and Diekema, 2012; Kotstanas et al., 2014; Luk et al.,2019) (Table 3).  
 
Within the studies there is emphasis on the composition of the antimicrobial textiles 
which are effective. To which, the curtains that contain QACs plus 
polyorganosiloxane were seen to be significantly more effective compared to 
individually built-in silver. The individual built-in silver lacked the significant efficacy 
against multi-drug resistant organisms (MRDOs). This included organisms such as 
methicillin resistant S. aureus (MRSA), carbapenem-resistant Acinetobacter spp. 
(CRA) and multidrug resistant Acinetobacter spp. (MDRA) (Luk et al., 2019).  
However, a study investigating the activity against C. difficile spores using silver-
lined antimicrobial curtains supported the previously mentioned opinion, that using a 
combination of metal nanoparticles such as silver, zinc, or copper with antimildew 
chemicals enables a significant reduction of microbial contamination on antimicrobial 
textiles compared to linen (Kotsanas et al., 2014). Another study involving 
antimicrobial textiles outlines the use of a “complex element compound” coming in 
the form of a textile interwoven with silver and copper. This study concluded that 
there was an increased time to a first detectable level of contamination and a 
significant reduction of bacterial contamination compared to that of a linen curtain 
(Boyken and Diekema, 2012).  
Another aspect to supporting the use of antimicrobial textiles is the inadequate 
laundering of linen in a clinical setting. NHS protocol for changing and laundering 
hospital curtains is a tiered system. Therefore, depending upon the ward, curtains 
will only be changed from every 6 months to two years, unless the curtains are 
visibly soiled (NHS, 2021). However, curtains can become contaminated the day 
they are hung without there being visible evidence of contamination. This means that 
potentially pathogenic microbes can be left for months and has the potential to 
spread from healthcare workers to patients and to visitors throughout the time in 
which the curtain is in place (Mitchell et al., 2015).  
 
3.3 Cost benefit analysis: 
 
Hanging antimicrobial curtains at face value may look very expensive (Kotsanas et 
al., 2014; Luk et al., 2019). However, the data presented in tables 1 and 2 both set 
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out the potential reduction in cost gained by using antimicrobial curtains versus a 
linen curtain. It is not only the mechanism by which the curtain works, but alleviation 
in terms labour is in terms of linen curtains being taken down, laundered and re hung 
that is also illustrated.   
 
3.4 Opposing use of antimicrobial curtains 
 
There is also evidence from studies of these antimicrobial curtains that the ISO and 
AATCC tests might not be a good enough representation of their effectiveness for 
extrapolation to a clinical setting. This is because data shows the presence of 
multiple microbes in-situ on supposedly antimicrobial curtains including, coagulase-
negative Staphylococci, Bacillus spp., Acinetobacter sp., Streptococcus spp., 
Pantoea spp., and Enterococcus faecalis (Sridhar et al., 2016). 
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Type of Antimicrobial textile Result of Antimicrobial textile Author(s) 
Silver and Copper salts embedded in 
fibres 
7 times longer for first contamination 
compared to standard curtain 
Rate of contamination was 29% lower 
versus normal curtains 
Boyken and Diekema, 2012 
A:  Built in silver   
Versus 
B: Quaternary ammonium chlorides 
(QACs) plus polyorganosiloxane 
 
Curtain B was superior to Curtain A in 
lowering microbial burden and MDRO 
contamination compared to standard 
curtains 
Curtain B vs standard curtain microbial 
loads: 
S. aureus: 0.5% vs 24% 
CRA: 0.2% vs 22.1% 
MDRA: 0% vs 13.2% 
Including curtain B exhibiting 27.6 times 
longer first contamination versus a 
standard curtain 
Luk et al.,2019 
Combination of silver, zinc or copper 
nanoparticles with antimildew chemicals 
Cost-effective solution for 6-monthly 
changing of curtains, saving $AUD 
1,431.30, compared to changing and 
laundering standard curtains in the 
same time frame 
Kotsanas et al., 2014 
Copper oxide-impregnated linens  
 
37% reduction of HAI Clostridium 




Copper-impregnated composite hard 
surfaces, bed linens and patient gowns  
 
 
28% reduction in total Clostridium 
difficile and multi drug resistant 
organisms MDRO.  
 
Burke and Butler, 2018 
 
Zinc Oxide (ZnO) nanoparticles with 
chitosan  
 
48% and 17% reduction of 
Staphylococcus aureus and Escherichia 
coli, respectively  
 





Potentially pathogenic microbes have been successfully proven to survive well on 
linen and some antimicrobial curtains. This includes survival after industrial/domestic 
laundering of linens, alongside outbreak management in hospitals. Evaluation of 
data and hypothesises from prior investigations support of the use of antimicrobial 
textiles to reduce disease transmission in hospitals. This conclusion was reached by 
analysis of the data which indicated there was a significant reduction in infection. 
The investigations so far have shown that when alone and not in combination the 
antimicrobial polymer is not nearly effective enough in reducing microbial loads on 
the textile. Having investigated a variety of polymers, the best combination of 
antimicrobials is yet to be concluded. This is because there is a plethora of 
parameters which require further investigation to ensure their efficacy. Finally, it has 
been highlighted that the antimicrobial curtains are cost effective in a clinical setting. 
These tables do not highlight the cost relating to HAIs, therefore the antimicrobial 
curtains could have an increased cost benefit with the alleviation of medicine and 
patient stay time.  After analysis of the ISO and AATCC testing methods for 
antimicrobial textiles it has been highlighted that there is a significant requirement for 
further testing on the antimicrobial textiles to ensure they are able to be effective in a 
clinical setting. This significance has been derived from supporting and opposing 
evidence which has been highlighted through investigations into challenge testing 
antimicrobial textiles.  Enhancing this study to attempt to include touch and aerosol 
transmission is another important factor when investigating opposing data. This links 
to which antimicrobial polymers are being used and the way they are incorporated 
in/onto the textile. Reflecting on the ‘industry standards’, there is not a superior test, 
instead using in combination and adding ‘second-tier testing’ to include aerosol and 
hand transmission will increase the efficacy of these testing methods. An interesting 
aspect of the study would be to know the cost benefit to the NHS or if there has been 
a cost analysis of antimicrobial textiles done in the UK. Therefore, there is a 
significant motivation to move forward with the study. The data generated by this 
study will add to existing data to help conclude the efficacy of the antimicrobial 
textiles. Improving the methodologies analysed throughout the literature will give the 





This study will follow the ISO22196, ISO20743 and AATCC TM100, with some 
deviation to attempt to include environmental conditions such as durability and 
temperature, with the aim to create a ‘realistic second-tier test’ (Martínez-Abad et al., 
2013) (ISO, 2011; ISO, 2013; AATCC, 2021). Durability is of the utmost of 
importance, as for use in a clinical setting in the UK, products must adhere to the 
Care Quality Commission (CQC) guidance. The ISO22196 and ISO20743 are the 
relevant methods to be following in our study to test antimicrobial surfaces to prove 
their antimicrobial efficacy. The ISO22196 method requires specific strains of E. coli 
and S. aureus to be inoculated onto the surface of treated and untreated fabrics as a 
comparative study (ISO, 2011). Similarly, the ISO20743 requires the use of specific 
strains of S. aureus and Klebsiella pneumonia (ISO, 2013). For both methods these 
strains can be substituted for different companies’ requirements. Prior investigations 
have included microbes such as MRSA, Pseudomonas aeruginosa, Salmonella typhi 
and Enterococcus faecalis (Panea et al., 2014; Campos et al., 2016; Aziman et al., 
2021), which increases the efficacy of both the ISO22196/ISO20743 standard to 
show that the material being tested has effective antimicrobial properties against 
multiple organisms. Some of the limitations of the ISO22196 include a lack of 
environmental controls such as humidity, UV exposure and the use of release 
agents. All of these limitations can vary hugely in a hospital which means products 
may pass the ISO tests, however they may not hold up in a clinical setting.  
 
In addition, ISO22196 and ISO20743 is based upon 24-hour exposure, whereas 
some of these antimicrobial products follow the Care Quality Commission guidance 
(CQC) (CQC, 2021), which means they can be hung for up to 6 months without 
requiring changing (Marlux medical, 2018). Therefore, in our investigation we intend 
to carry out the tests which have already been done to ensure supporting data. In 
addition, we can then take the process further to incorporate all necessary conditions 
to increase the viability of data collected. 
 
 
Both hand and aerosol contamination will be simulated to ensure the same 
conditions are met for challenge testing the antimicrobial material. To simulate hand-
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touching in the lab, a novel method will be developed to achieve reproduceable 
results. This method will involve preparation of known concentrations of organism, 
which will be used to inoculate a sterile gloved hand. The gloved hand will be 
pressed onto the fabric, and then, in accordance with ISO22916 and ISO20743, the 
fabric will be placed into the necessary agar for optimal growth conditions (including 
nutrient agar, temperature, pH, etc.) for propagation of the inoculating organism. This 
novel method simulates the scenario in which a healthcare worker is wearing 
contaminated gloves and touches the surface. Transmission via un-gloved skin must 
also be replicated, as this is a very ecologically viable mode of transmission.  
The re-creation of skin touch transmission can be obtained through contaminating 
Gamma-irradiated pigskin substrates (Leitgeb et al., 2013). In order to apply this to 
the study, a similar protocol to Leitgeb et al (2013) will be used to ensure that the 
pigskin is completely sterile before challenge testing. Once sterile, the novel 
approach can be used, via inoculating the pigskin with known concentrations of 
organism, then press the skin down onto a treated and untreated sample of fabric. 
From this point the ISO22016, ISO20743 and AATCC TM100 protocol for plating and 




























A. Pinon, J. Gachet, V. Alexandre, S. Decherf and M. Vialette, "Microbiological 
Contamination of Bed Linen and Staff Uniforms in a Hospital," Advances in 
Microbiology, Vol. 3 No. 7, 2013, pp. 515-519. doi: 10.4236/aim.2013.37069. 
 
Atiyeh, B.S., Costagliola, M., Hayek, S.N. and Dibo, S.A., 2007. Effect of silver on 
burn wound infection control and healing: review of the literature. Burns, 33(2), 
pp.139-148. 
 
Aziman, N., Kian, L.K., Jawaid, M., Sanny, M. and Alamery, S., 2021. Morphological, 
Structural, Thermal, Permeability, and Antimicrobial Activity of PBS and PBS/TPS 
Films Incorporated with Biomaster-Silver for Food Packaging 
Application. Polymers, 13(3), p.391. 
 
Betina, V., 1989. Bioactive molecules. Mycotoxins: Chemical, Biological and 
Environmental Aspects, 9, p. 000-000 
 
Bienert, A., Scheller, S., Keane, E., Mullooly, G. and Mohan, F., 2006. Application of 
terrestrial laser scanners for the determination of forest inventory 
parameters. International Archives of Photogrammetry, Remote Sensing and Spatial 
Information Sciences, 36(5), pp.1-5. 
 
Boyken, L. and Diekema, D., 2012. Novel hospital curtains with antimicrobial 
properties: a randomized, controlled trial. Infection control and hospital 
epidemiology, 33(11), pp.000-000. 
 
Bult, A. and Plug, C.M., 1984. Silver sulfadiazine. In Analytical Profiles of Drug 
Substances (Vol. 13, pp. 553-571). Academic Press. 
 
Butler, J.P., 2018. Effect of copper-impregnated composite bed linens and patient 
gowns on healthcare-associated infection rates in six hospitals. Journal of Hospital 
Infection, 100(3), pp.e130-e134. 
 
Bureš, F., 2019. Quaternary ammonium compounds: simple in structure, complex in 
application. Topics in Current Chemistry, 377(3), pp.1-21. 
 
Burke, G.H. and Butler, J.P., 2018. Analysis of the role of copper impregnated 
composite hard surfaces, bed linens and patient gowns in reducing healthcare-
associated infection rates. International Journal of Infection Control, 14(1). 
 
Cadnum, J., Mana, T., Jencson, A., Thota, P., Kundrapu, S. and Donskey, C., 
2015. Effectiveness of a hydrogen peroxide spray for decontamination of soft 
surfaces in hospitals. American Journal of Infection Control, 43 (12), pp. 1357-1359 
 
Caillier, L., de Givenchy, E.T., Levy, R., Vandenberghe, Y., Géribaldi, S. and 
Guittard, F., 2009. Synthesis and antimicrobial properties of polymerizable 




Campos, M.D., Zucchi, P.C., Phung, A., Leonard, S.N. and Hirsch, E.B., 2016. The 
activity of antimicrobial surfaces varies by testing protocol utilized. Plos One, 11(8), 
p.e0160728. 
 
Carraro, V., Sanna, A., Pinna, A., Carrucciu, G., Succa, S., Marras, L., Bertolino, G. 
and Coroneo, V., 2020. Evaluation of Microbial Growth in Hospital Textiles Through 
Challenge Test. Advances in Microbiology, Infectious Diseases and Public Health 
(Vol. 1323, pp. 19-34) 
 
Castellano, J.J., Shafii, S.M., Ko, F., Donate, G., Wright, T.E., Mannari, R.J., Payne, 
W.G., Smith, D.J. and Robson, M.C., 2007. Comparative evaluation of silver-
containing antimicrobial dressings and drugs. International wound journal, 4(2), 
pp.114-122. 
 
Clement, J.L. and Jarrett, P.S., 1994. Antibacterial silver. Metal-based Drugs, 1(5-6), 
pp.467-482. 
 
Cornejo-Juárez, P., Vilar-Compte, D., Pérez-Jiménez, C., Namendys-Silva, S.A., 
Sandoval-Hernández, S. and Volkow-Fernández, P., 2015. The impact of hospital-
acquired infections with multidrug-resistant bacteria in an oncology intensive care 
unit. International Journal of Infectious Diseases, 31, pp.31-34. 
 
Cqc.org.uk. 2021. The fundamental standards | Care Quality Commission. [online] 
Available at: <https://www.cqc.org.uk/what-we-do/how-we-do-our-job/fundamental-
standards> [Accessed 13 May 2021]. 
 
Durán, N., Nakazato, G. and Seabra, A.B., 2016. Antimicrobial activity of biogenic 
silver nanoparticles, and silver chloride nanoparticles: an overview and 
comments. Applied microbiology and biotechnology, 100(15), pp.6555-6570. 
 
Eames, I., Tang, J.W., Li, Y. and Wilson, P., 2009. Airborne transmission of disease 
in hospitals. Journal of the Royal Society Interface, 6(suppl_6), pp.S697-S702. 
 
Feng, Q.L., Wu, J., Chen, G.Q., Cui, F.Z., Kim, T.N. and Kim, J.O., 2000. A 
mechanistic study of the antibacterial effect of silver ions on Escherichia coli and 




Fijan, S., Koren, S., Cencič, A. and Šostar-Turk, S., 2007. Antimicrobial disinfection 
effect of a laundering procedure for hospital textiles against various indicator bacteria 
and fungi using different substrates for simulating human excrements. Diagnostic 
microbiology and infectious disease, 57(3), pp.251-257. 
 
Fijan, S., Pahor, D. and Šostar Turk, S., 2017. Survival of Enterococcus faecium, 
Staphylococcus aureus and Pseudomonas aeruginosa on cotton. Textile Research 
Journal, 87(14), pp.1711-1721. 
 
Flügge, C., 1897. Ueber luftinfection. Zeitschrift für Hygiene und 
Infektionskrankheiten, 25(1), pp.179-224. 
 26 
 
Fox, C.L. and Modak, S.M., 1974. Mechanism of silver sulfadiazine action on burn 
wound infections. Antimicrobial agents and chemotherapy, 5(6), pp.582-588. 
 
Fredell, D.L., 2019. Biological properties and applications of cationic surfactants. 
In Catonic Surfactants (pp. 31-60). CRC Press. 
 
Fuller, F.W., 2009. The side effects of silver sulfadiazine. Journal of burn care & 
research, 30(3), pp.464-470. 
 
Gallagher, J.J., Williams-Bouyer, N., Villarreal, C., Heggers, J.P. and Herndon, D.N., 
2007. Treatment of infection in burns. Total Burn Care. Philadelphia: Elsevier, Inc, 
pp.136-176. 
 
Gao, D., Li, Y., Lyu, B., Lyu, L., Chen, S. and Ma, J., 2019. Construction of durable 
antibacterial and anti-mildew cotton fabric based on P (DMDAAC-AGE)/Ag/ZnO 
composites. Carbohydrate Polymers, 204, pp.161-169. 
 
Gilbert, P. and Moore, L.E., 2005. Cationic antiseptics: diversity of action under a 
common epithet. Journal of applied microbiology, 99(4), pp.703-715. 
 
Gong, P., Li, H., He, X., Wang, K., Hu, J., Tan, W., Zhang, S. and Yang, X., 2007. 
Preparation and antibacterial activity of Fe3O4@ Ag 
nanoparticles. Nanotechnology, 18(28), p.285604. 
 
Guest, J.F., Keating, T., Gould, D. and Wigglesworth, N., 2020. Modelling the annual 
NHS costs and outcomes attributable to healthcare-associated infections in 
England. BMJ open, 10(1), p.e033367. 
 
Gupta, A. and Silver, S., 1998. Molecular genetics: silver as a biocide: will resistance 
become a problem?. Nature Biotechnology, 16(10), pp.888-888. 
 
Gupta, A., Maynes, M. and Silver, S., 1998. Effects of halides on plasmid-mediated 
silver resistance in Escherichia coli. Applied and environmental microbiology, 64(12), 
pp.5042-5045. 
 
Hamid, M., Nawaz, B. and Afshan, N., 2016. White coats: A possible source of 
nosocomial infections. PSM Biological Research, 1(1), pp.1-5. 
 
Hegstad, K., Langsrud, S., Lunestad, B.T., Scheie, A.A., Sunde, M. and 
Yazdankhah, S.P., 2010. Does the wide use of quaternary ammonium compounds 
enhance the selection and spread of antimicrobial resistance and thus threaten our 
health?. Microbial drug resistance, 16(2), pp.91-104. 
 
Hellickson, L.A. and Owens, K.L., 2007. Cross-contamination of Clostridium difficile 




Honisch, M., Stamminger, R. and Bockmühl, D.P., 2014. Impact of wash cycle time, 
temperature and detergent formulation on the hygiene effectiveness of domestic 
laundering. Journal of applied microbiology, 117(6), pp.1787-1797. 
 
Hui, A., Liu, J. and Ma, J., 2016. Synthesis and morphology-dependent antimicrobial 
activity of cerium doped flower-shaped ZnO crystallites under visible light 
irradiation. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 506, 
pp.519-525. 
ISO 20743:2013(E), Textiles — Determination of antibacterial activity of textile 
products. [online] Available at: https://www.iso.org/standard/59586.html [Accessed 
30 June 2021]. 
ISO 22196:2011(E), Measurement of antibacterial activity on plastics and other non-
porous surfaces. [online] Available at: < https://www.iso.org/standard/54431.html> 
[Accessed 30 June 2021]. 
Jones, E.G., 1994. Fungal adhesion. Mycological Research, 98(9), pp.961-981. 
Kazachenko, A.S., Legler, A.V., Per'yanova, O.V. and Vstavskaya, Y.A., 2000. 
Synthesis and antimicrobial activity of silver complexes with histidine and 
tryptophan. Pharmaceutical Chemistry Journal, 34(5), pp.257-258. 
 
Klasen, H.J., 2000. A historical review of the use of silver in the treatment of burns. 
II. Renewed interest for silver. Burns, 26(2), pp.131-138. 
 
Knetsch, M.L. and Koole, L.H., 2011. New strategies in the development of 
antimicrobial coatings: the example of increasing usage of silver and silver 
nanoparticles. Polymers, 3(1), pp.340-366. 
 
Kotsanas, D. and Gillespie, E., 2016. Disposable antimicrobial and sporicidal privacy 
curtains: Cost benefit of hanging longer. American journal of infection control, 44(7), 
pp.854-855. 
 
Kotsanas, D., Wijesooriya, W.R.P.L.I., Sloane, T., Stuart, R.L. and Gillespie, E.E., 
2014. The silver lining of disposable sporicidal privacy curtains in an intensive care 
unit. American journal of infection control, 42(4), pp.366-370. 
Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on 
inanimate surfaces? A systematic review. BMC Infect Dis 2006;6:130.  
Lamprea, M.R., Cardenas, F.P., Setem, J. and Morato, S., 2008. Thigmotactic 
responses in an open-field. Brazilian Journal of Medical and Biological 
Research, 41(2), pp.135-140. 
 
Lansdown, A.B., 2002. Silver I: its antibacterial properties and mechanism of 
action. Journal of wound care, 11(4), pp.125-130. 
 
Leitgeb, J., Schuster, R., Eng, A.H., Yee, B.N., Teh, Y.P., Dosch, V. and Assadian, 
O., 2013. In-vitro experimental evaluation of skin-to-surface recovery of four bacterial 
 28 
species by antibacterial and non-antibacterial medical examination 
gloves. Antimicrobial resistance and infection control, 2(1), pp.1-6. 
 
Liao, C., Li, Y. and Tjong, S.C., 2019. Bactericidal and cytotoxic properties of silver 
nanoparticles. International journal of molecular sciences, 20(2), p.449-450. 
 
Luk, S., Chow, V., Yu, K., Hsu, E., Tsang, N., Chuang, V., Lai, C., Hui, M., Lee, R., 
Lai, W., Que, T., Fung, S., To, W., Cheng, V. and Wong, A., 2019. Effectiveness of 
antimicrobial hospital curtains on reducing bacterial contamination—A multicenter 
study. Infection Control & Hospital Epidemiology, 40(2), pp.164-170. 
 
Liu, L., Wei, J., Li, Y. and Ooi, A., 2017. Evaporation and dispersion of respiratory 
droplets from coughing. Indoor Air, 27(1), pp.179-190. 
 
Madigan, M., Martinko, J., Bender, K., Buckley, D. and Stahl, D., 2015. Brock 
Biology of Microorganisms, Global Edition. 14th ed. United Kingdom: Pearson 
Education Limited, pp.580-582. 
 
Maple, P.A.C., Hamilton-Miller, J.M.T. and Brumfitt, W., 1992. Comparison of the in-
vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver 
sulphadiazine and mupirocin against methicillin-resistant Staphylococcus 
aureus. Journal of antimicrobial chemotherapy, 29(6), pp.661-668. 
 
Marini, M., Bondi, M., Iseppi, R., Toselli, M. and Pilati, F., 2007. Preparation and 
antibacterial activity of hybrid materials containing quaternary ammonium salts via 
sol–gel process. European Polymer Journal, 43(8), pp.3621-3628. 
 
Marluxmedical.com. 2018. [online] Available at: 
<https://www.marluxmedical.com/faq> [Accessed 10 May 2021]. 
 
Martínez-Abad, A., Ocio, M.J., Lagarón, J.M. and Sánchez, G., 2013. Evaluation of 
silver-infused polylactide films for inactivation of Salmonella and feline calicivirus in 
vitro and on fresh-cut vegetables. International journal of food microbiology, 162(1), 
pp.89-94. 
 
May, K.R., 1973. The Collison nebulizer: description, performance and 
application. Journal of Aerosol Science, 4(3), pp.235-243. 
McDonnell, G. and Russell, A.D., 1999. Antiseptics and disinfectants: activity, action, 
and resistance. Clinical microbiology reviews, 12(1), pp.147-179. 
Mitchell, B.G., Dancer, S.J., Anderson, M. and Dehn, E., 2015. Risk of organism 
acquisition from prior room occupants: a systematic review and meta-
analysis. Journal of Hospital Infection, 91(3), pp.211-217. 
 
Members.aatcc.org. 2021. AATCC - AATCC. [online] Available at: 
<https://members.aatcc.org/store/tm100/513/> [Accessed 14 June 2021]. 
 
Modjarrad, K. and Ebnesajjad, S. eds., 2013. Handbook of polymer applications in 
medicine and medical devices. Elsevier. 
 
 29 
Morones, J.R., Elechiguerra, J.L., Camacho, A., Holt, K., Kouri, J.B., Ramírez, J.T. 
and Yacaman, M.J., 2005. The bactericidal effect of silver 
nanoparticles. Nanotechnology, 16(10), p.2346. 
 
Moyer, C.A., BRENTANO, L., GRAVENS, D.L., MARGRAF, H.W. and MONAFO, 
W.W., 1965. Treatment of large human burns with 0.5% silver nitrate 
solution. Archives of Surgery, 90(6), pp.812-867. 
 
Nayak, R. and Padhye, R., 2014. Antimicrobial finishes for textiles (pp. 361-385). 
Woodhead Publishing: Cambridge, UK. 
 
Neely, A.N. and Maley, M.P., 2000. Survival of enterococci and staphylococci on 
hospital fabrics and plastic. Journal of clinical microbiology, 38(2), pp.724-726. 
 
 
Neely, A.N., 2000. A survey of gram-negative bacteria survival on hospital fabrics 
and plastics. The Journal of burn care & rehabilitation, 21(6), pp.523-527. 
 
NHS, 2021. National Standards of Healthcare and Cleanliness 2021. [online] 
Available at: <https://www.england.nhs.uk/wp-content/uploads/2021/04/B0271-
national-standards-of-healthcare-cleanliness-2021.pdf> [Accessed 30 June 2021]. 
 
 
Nohr, R.S. and Gavin Macdonald, J., 1994. New biomaterials through surface 
segregation phenomenon: new quaternary ammonium compounds as antibacterial 
agents. Journal of Biomaterials Science, Polymer Edition, 5(6), pp.607-619. 
 
Nordstrom, J.M., Reynolds, K.A. and Gerba, C.P., 2012. Comparison of bacteria on 
new, disposable, laundered, and unlaundered hospital scrubs. American journal of 
infection control, 40(6), pp.539-543. 
 
Ohl, M., Schweizer, M., Graham, M., Heilmann, K., Boyken, L. and Diekema, D., 
2012. Hospital privacy curtains are frequently and rapidly contaminated with 
potentially pathogenic bacteria. American journal of infection control, 40(10), pp.904-
906. 
 
Owen, L. and Laird, K., 2020. The role of textiles as fomites in the healthcare 
environment: a review of the infection control risk. PeerJ, 8, p.e9790. 
 
Panea, B., Ripoll, G., González, J., Fernández-Cuello, Á. and Albertí, P., 2014. 
Effect of nanocomposite packaging containing different proportions of ZnO and Ag 
on chicken breast meat quality. Journal of Food Engineering, 123, pp.104-112. 
 
Petkova, P., Francesko, A., Fernandes, M.M., Mendoza, E., Perelshtein, I., 
Gedanken, A. and Tzanov, T., 2014. Sonochemical coating of textiles with hybrid 




Pinon, A., Gachet, J., Alexandre, V., Decherf, S. and Vialette, M., 2013. 
Microbiological contamination of bed linen and staff uniforms in a hospital. Advances 
in Microbiology, 2013. 
 
Pubchem.ncbi.nlm.nih.gov. 2021. 4-Aminobenzoic acid. [online] Available at: 
<https://pubchem.ncbi.nlm.nih.gov/compound/4-Aminobenzoic-acid> [Accessed 4 
June 2021]. 
 
Rai, M., Yadav, A. and Gade, A., 2009. Silver nanoparticles as a new generation of 
antimicrobials. Biotechnology Advances, 27(1), pp.76-83. 
 
Ravikumar, T., Murata, H., Koepsel, R.R. and Russell, A.J., 2006. Surface-active 
antifungal polyquaternary amine. Biomacromolecules, 7(10), pp.2762-2769. 
 
Riley, K., Williams, J., Owen, L., Shen, J., Davies, A. and Laird, K., 2017. The effect 
of low-temperature laundering and detergents on the survival of Escherichia coli and 
Staphylococcus aureus on textiles used in healthcare uniforms. Journal of Applied 
Microbiology, 123(1), pp.280-286. 
 
Rosenkranz, H.S. and Rosenkranz, S., 1972. Silver sulfadiazine: interaction with 
isolated deoxyribonucleic acid. Antimicrobial Agents and Chemotherapy, 2(5), p.373. 
Sandmann, B.J., Nesbitt Jr, R.U. and Sandmann, R.A., 1974. Characterization of 
silver sulfadiazine and related compounds. Journal of pharmaceutical 
sciences, 63(6), pp.948-951. 
 
Schweizer, M., Graham, M., Ohl, M., Heilmann, K., Boyken, L. and Diekema, D., 
2012. Novel hospital curtains with antimicrobial properties: a randomized, controlled 
trial. Infection Control & Hospital Epidemiology, 33(11), pp.1081-1085. 
 
Sexton, J.D., Wilson, A.M., Sassi, H.P. and Reynolds, K.A., 2018. Tracking and 
controlling soft surface contamination in health care settings. American journal of 
infection control, 46(1), pp.39-43. 
 
Simoncic, B. and Tomsic, B., 2010. Structures of novel antimicrobial agents for 
textiles-a review. Textile Research Journal, 80(16), pp.1721-1737. 
 
Singh, P. and Nanda, A., 2013. Antimicrobial and antifungal potential of zinc oxide 
nanoparticles in comparison to conventional zinc oxide particles. J Chem Pharm 
Res, 5(11), pp.457-463. 
 
 
Sridhar, S.A., Ledeboer, N.A., Nanchal, R.S., Mackey, T., Graham, M.B., 
VanDerSlik, A. and Munoz-Price, L.S., 2016. Antimicrobial Curtains: Are They as 
Clean as You Think?. infection control & hospital epidemiology, 37(10), pp.1260-
1262. 
 
Sun, Q., Li, J. and Le, T., 2018. Zinc oxide nanoparticle as a novel class of antifungal 
agents: current advances and future perspectives. Journal of agricultural and food 
chemistry, 66(43), pp.11209-11220. 
 
 31 
Thorsteinsson, T., Loftsson, T. and Masson, M., 2003. Soft antibacterial 
agents. Current medicinal chemistry, 10(13), pp.1129-1136. 
 
Treakle, A.M., Thom, K.A., Furuno, J.P., Strauss, S.M., Harris, A.D. and 
Perencevich, E.N., 2009. Bacterial contamination of health care workers' white 
coats. American journal of infection control, 37(2), pp.101-105. 
 
Trick, W.E., Vernon, M.O., Hayes, R.A., Nathan, C., Rice, T.W., Peterson, B.J., 
Segreti, J., Welbel, S.F., Solomon, S.L. and Weinstein, R.A., 2003. Impact of ring 
wearing on hand contamination and comparison of hand hygiene agents in a 
hospital. Clinical infectious diseases, 36(11), pp.1383-1390. 
 
Trillis F, Eckstein EC, Budavich R, Pultz MJ, Donskey CJ. 2008. Contamination of 
hospital curtains with healthcare-associated pathogens. Infect Control Hosp 
Epidemiol 29;1074–1076.  
Turgeon, N., Toulouse, M.J., Martel, B., Moineau, S. and Duchaine, C., 2014. 
Comparison of five bacteriophages as models for viral aerosol studies. Applied and 
environmental microbiology, 80(14), pp.4242-4250. 
 
Wang, M., Zhang, M., Pang, L., Yang, C., Zhang, Y., Hu, J. and Wu, G., 2019. 
Fabrication of highly durable polysiloxane-zinc oxide (ZnO) coated polyethylene 
terephthalate (PET) fabric with improved ultraviolet resistance, hydrophobicity, and 
thermal resistance. Journal of colloid and interface science, 537, pp.91-100. 
 
Wang, X. and Wang, C., 2009. The antibacterial finish of cotton via sols containing 
quaternary ammonium salts. Journal of sol-gel science and technology, 50(1), pp.15-
21. 
 
Wilson, G., Jackson, V., Boyken, L., Puig-Asensio, M., Marra, A.R., Perencevich, E., 
Schweizer, M.L., Diekema, D., Breheny, P. and Petersen, C., 2020. A randomized 
control trial evaluating efficacy of antimicrobial impregnated hospital privacy curtains 
in an intensive care setting. American journal of infection control, 48(8), pp.862-868. 
 
Woodland, R., Whitham, D., O'Neil, B. and Otter, S., 2010. Microbiological 
contamination of cubicle curtains in an out-patient podiatry clinic. Journal of foot and 
ankle research, 3(1), pp.1-6. 
 
World Health Organization, 2009. WHO guidelines on hand hygiene in health care: 
first global patient safety challenge clean care is safer care. World Health 
Organization. [online] Available at: 
https://www.who.int/gpsc/5may/tools/who_guidelines-handhygiene_summary.pdf 
[Accessed 30 June 2021]. 
 
Yeo, S.Y. and Jeong, S.H., 2003. Preparation and characterization of 




Zimmermann, R., Dukhin, S. and Werner, C., 2001. Electrokinetic measurements 
reveal interfacial charge at polymer films caused by simple electrolyte ions. The 
Journal of Physical Chemistry B, 105(36), pp.8544-8549. 
 
Zuo, Z., de Abin, M., Chander, Y., Kuehn, T.H., Goyal, S.M. and Pui, D.Y., 2013. 
Comparison of spike and aerosol challenge tests for the recovery of viable influenza 














Author for correspondence: Mr George Blackburn Tel: 0115 9516161, Fax: 0115 
9516142. Address: The School of Biosciences, University of Nottingham, Sutton 
Bonington, Loughborough LE12 5RD E-mail: stygmb@nottingham.ac.uk 
Host company: Marlux Medical 
Keywords: Textile, Curtain, Linen, Antimicrobial 
Report/Research paper submitted to The University of Nottingham in partial 






















Main text: 3926 




1 Introduction……………………………………………………………………………. 4 
 
Materials and Methods.……………………………………………………............... 6 
2.1 Chemicals and Media………………………….………………………………….. 6 
2.2 Bacterial strains and Growth conditions…………..……………………………...7 
2.3 Transfer method of ISO20743……………………………………………………..7 
2.3.1 Incubation of test strains...............................................................................8 
2.3.2 Monitoring growth of bacterial cultures.........................................................8 
2.3.3 Preparation of treated/untreated textile and inoculation of agar plates........8 




3.1 Experimental aim and design.………….…….……………………………….....10 
3.2 Challenge testing……………………………..........................................…….. 11 
3.3 Challenge testing with added parameters……………………………………...12 
3.3.1 Touch transmission……………………………………………………………..12 




4.1 Overview…………………………………………………………………………... 16 
4.1.2 Staphylococcus aureus…………………………….....................…………….16 
4.1.3 Enterococcus faecalis…………………………………………………………..17 
4.1.4 Pseudomonas aeruginosa.……...................................……………………..17 
 
Conclusions …..................……………………………..…………………….……..18 
















Objective: A comparative study to determine the antibacterial activity of Marlux 
Medical silver embedded curtain versus the same untreated material, with the 
addition of simulated aerosol and touch transmission methods using a uniquely 
developed procedure in-line with ISO20743 and ISO22196. 
Design: A unique challenge test model replicable to a clinical setting, including 
aerosol and touch transmission as a study with a duration of 6 weeks. 
Setting: The study was performed ex situ in a category II laboratory at the University 
of Nottingham, Sutton Bonnington Campus.  
Method: All equipment and solutions were prepared as described in ISO20473. Test 
organisms include Staphylococcus aureus, Enterococcus faecalis, Pseudomonas 
aeruginosa. Cultures were confirmed prior to use by growth on selective agar. A 
unique methodology was developed and evaluated in comparison with the ISO20473 
‘transfer method’ as a control. Further modifications to the ISO method were made to 
simulate aerosol and touch transmission as part of the unique methodology.  
Results: When tested against S. aureus and E. faecalis, the curtains passed the 
ISO20473 standard for ‘antibacterial activity’, both producing <2 log10 reduction. 
However, when the curtains were tested using P. aeruginosa, the curtains did not 
pass any of the ISO standards, indicating that the treated curtain had insufficient 
antibacterial activity against this organism. With the unique simulated transfer 
methods, the highest reduction in microbial load recorded was 1.92 log10  and the 
lowest showing 0.07 log10 , suggesting that the method of transfer can profoundly 














With recent catastrophic global events seen through the COVID-19 pandemic, there 
is a heightened awareness surrounding the spread of disease, especially in 
hospitals. Organisations such as the National Health Service (NHS) and the National 
Institute for Health and Care Excellence (NICE) have developed procedures to help 
reduce transmission of disease in hospitals. One example is ‘bare below the elbow’ 
whereby shortening the sleeves of healthcare workers facilitates more rigorous hand 
hygiene practices (NHS, 2021). Unfortunately, despite these measures, hospital 
acquired infections (HAIs) are estimated to have cost the NHS £2.1 billion in 
2016/2017 (Guest et al., 2020). In addition to this 39.5% of the HAI producing 
bacteria causing HAIs are multi-drug resistant organisms (MDROs), including 
multi/methicillin resistant Staphylococcus aureus (MRSA), vancomycin resistant 
Enterococci (VRE) and Clostridium difficile, therefore it is paramount that there are 
increased investigations into interventions that can reduce disease transmission in 
clinical settings (Cornejo-Juárez et al., 2015; Ohl et al., 2012).  
 
To enable successful investigations, clinical settings must be fully examined to 
understand how and where disease can be transmitted. One vector for disease 
transmission is privacy curtains. Standard linen privacy curtains are particularly 
outdated, with many studies proving that they harbour nosocomial bacteria (Pinon et 
al., 2013; Fijan et al., 2007; Kramer et al., 2006; Trillis et al., 2008; Ohl et al., 2012).  
One issue identified for linen privacy curtains is inadequate laundering practices, 
with evidence that certain species of Enterococci can survive laundering at 71 oC 
(Orr et al., 2002). In addition, depending on the ward, privacy curtains can be hung 
for months, or even years, unless they are visibly soiled (Woodland et al., 2010; 
Owen and Laird., 2020; NHS, 2020). As a result, the textile becomes a fomite for 
disease as healthcare workers, patients, and visitors can all potentially can touch the 
contaminated curtain throughout the time it is hung. The final issue with standard 
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privacy curtains is the cost of changing them from linen to disposable or antimicrobial 
textiles. Therefore, alleviation of cost must be confirmed to be able to justify such a 
huge investment for hospitals and there have been various studies to convey cost 
alleviation, but none in the UK. Therefore investigations into the factors surrounding 
cost of HAIs and using standard linen curtains compared to that of treated curtains in 
the UK must be undertaken (Kotsanas et al., 2014; Luk et al., 2018).  
 
To tackle contaminated linen or disposable curtains, antimicrobial curtains have 
been developed with a variety of antimicrobials either woven into, or embedded 
within, the fabrics.  
The focus of this study was Marlux Medical privacy curtains which are embedded 
with Microbans SilverShield technology. Silver is a well-established antimicrobial, 
known for its broad range of activity against a diverse range of microbes (Moyer et 
al., 1965; Fox and Modak, 1974; Rai et al., 2009). Applications of silver in clinical 
settings comes in a variety of forms, including the use of silver nanoparticles, which 
is a particle that ranges between 1 and 100 nanometres in size. These nanoparticles 
have extremely different physical and chemical properties compared to their larger 
particle equivalents; therefore, this is the most modern approach to using silver. In 
addition, a large surface area contributes to the extreme efficacy of silver 
nanoparticles, resulting in more successful contact with, and therefore killing of, the 
microorganisms (Atiyeh et al., 2007; Durán et al.,2016).  
 
The efficacy of antimicrobial textiles is determined by a variety of tests including 
methods defined by the International Organisation of Stand (ISO) (ISO, 2013; ISO, 
2019) and the American Association of Textile Chemists and Colourist (AATCC) 
(AATCC, 2021).  However, these standardised methods come with little 
consideration of the different types of transmission that may occur in a practical 
setting. Instead, the ISO20743 ‘transfer method’ is used to simulate prolonged 
contact between textile and organism. To make the study applicable to a clinical 
setting, the two most common modes of transmission of microbes onto the fabric 
should be addressed; namely touch and aerosol. With addition of these parameters, 
the textiles will be put under more advanced challenges in killing the concentration of 
bacteria placed onto them. One of the aims of the study is to understand how the 
test organisms behave when applied to the textile by these different routes. 
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Specifically, to understand whether different organisms are still affected by the 
antibacterial product on the curtain if applied this way.  
 
There are studies which illustrate the effectiveness of the antimicrobial curtains after 
a significant amount of time (Luk et al., 2019), however there are no studies 
specifically on Marlux Medical fabrics with additional ‘second-tier’ testing alongside 
the ISO standards. This procedure will be carried out via a novel methodology, 
based on the methods described in ISO20743 and ISO22196 (ISO, 2013; ISO, 
2019). This novel methodology will allow for accurate calculations of ‘antibacterial 
activity’ as described in ISO20743 for the ‘second-tier’ testing (ISO, 2013). This 





It is suggested in previous studies that using the ISO standards will detect effective 
‘antibacterial-activity’ against the test organisms. However, any variations of 
inoculation on the textile may reveal a drop in viability of >2 log10 as described in 
ISO20743 meaning the textile may not be deemed fit for use in a clinical setting.  
 
Materials and Methods  
 
2.1 Chemicals and Media 
 
Specifics of solutions and media used in the study are presented Table 2.1. 
Suppliers of all chemical substances and media used in this thesis are listed in Table 
2.1. All solutions and media used in the study were prepared to either as described 
by the manufacturers standards or according to the method specified in the 
ISO20474 standard.  
 
Table 2.1 Chemical substances and media used during this study  
Compound Supplier 
Nutrient Broth No.2 (CM0067) Oxoid, UK Ltd 
Nutrient Agar (CM0003B) Oxoid, UK Ltd 
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Pseudomonas Agar (CM0559) Oxoid, UK Ltd 
Glycerol (G5516) Sigma-Aldrich, UK Ltd 
Bile Aesculin Agar (CM0888) Oxoid, UK Ltd 
Baird-Parker Agar (CM0961) Oxoid, UK Ltd 
Brain Heart Infusion Agar (CM1136) Oxoid, UK Ltd 
Egg Yolk Tellurite Emulsion (SR0054) Oxoid, UK Ltd 
Sodium Chloride (NaCl) Fisher Scientific, UK Ltd 
Tryptone (LP0042B) Fisher Scientific, UK Ltd 
Tween 80 Fisher Scientific, UK Ltd 
Potassium Phosphate Monobasic (KH2PO4) Fisher Scientific, UK Ltd 
Sodium phosphate dibasic dihydrate (Na2HPO4•H2O) Fisher Scientific, UK Ltd 
L-alpha-Lecithin, granular from soybean oil Acros Organics B.V.B.A 
L-Histidine Hydrochloride (C9H9N3O2.HCl.H2O) Fisher Scientific, UK Ltd 
 
 
2.2 Bacterial strains and growth conditions 
 
Bacterial strains used in the study are described in table 2.2. These strains were 
obtained from the laboratory stocks of Microbiology, Brewing and Biotechnology 
Division, University of Nottingham, United Kingdom. An single colony was initially 
obatained and inoculated into 20ml of nutrient broth and samples were incubated 
overnight at 37oC in a rotary shaking incubator at 150 rpm. Following overnight 
incubation in broth, all cultures were streaked onto nutrient agar and incubated 
overnight at 37oC. Finally, to confirm the presence of target bacteria, each sample 
was streaked onto selective media. S. aureus onto Baird-Parker agar, E. faecalis 
onto Bile Aesculin agar and P. aeruginosa on Pseudomonas selective agar. 
Overnight incubation allowed each culture to reach a density of approximately 1 x 
109 cfu, ml-1 throughout the study. To prepare fresh liquid cultures, 200µl of each 
culture was sub-cultured into 20ml of nutrient broth daily to ensure fresh stock was 
used in each separate investigation. 
 
Table 2.2 Bacterial strains used throughout study 
 
Bacteria Strain Number  Selective agar used 
Staphylococcus aureus  UoN SuperLab Stock Baird-Parker agar 
Enterococcus faecalis NCTC775 Bile Aesculin agar 
Pseudomonas aeruginosa  UoN SuperLab Stock Pseudomonas selective 
 
2.3 Transfer method of ISO20743 
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Following the international standard (ISO) 20743 entitled; ‘Textiles- Determination of 
antibacterial activity of textile products’, the ‘transfer method’ was followed as 
described in the sections below, with modifications of using selective agar for 
specified strains in Table 2.2.  
 
2.3.1 Incubation of test strains  
 
Once isolated cultures had been confirmed, a single colony for each organism was 
inoculated into 20 ml of nutrient broth and incubated overnight before being sub-
cultured (see section 2.2). As specified in ISO20743, the second transfer constitutes 
the working culture(s).  
 
2.3.2 Monitoring growth of bacterial cultures  
 
After overnight incubation, culture growth was determined using Optical Density 
(OD600nm) and the density of culture was adjusted using peptone-salt solution as a 
diluent to OD600nm = 0.5 (approximately 1x108 cfu ml-1). All cultures were used 
immediately post dilution in experiments. The viable count (cfu ml-1) was determined 
by performing a serial dilution and plating using the Miles and Misra Method (3 
sample of 10 µl used per dilution). When bacteria were recovered from the surface of 
textiles, samples were plated on appropriate selective agar and incubated overnight 
at 37 oC (see table 2.2). After incubation the number of colonies were counted in the 
range of 3-30. When the number was less than 30 in the petri dishes, the cell 
number was used to calculate the average number. When the number of viable 
bacteria was less than 1 the average number was rounded up to 1. 
 
 2.3.3 Preparation of treated/untreated textile and inoculation of agar plates.  
 
Working in a Class II Biological Safety Cabinet, 10 specimens of textile were cut out 
using a circular 3.8 cm diameter template.  Of which, 5 specimens were treated and 
5 were untreated textile. Then 1ml of the test inoculum was spread evenly onto the 
appropriate selective agar plates, using a sterile spreader and then excess liquid 
was removed using a pipette, and the plates left to stand for 300 s ± 30 s.  
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Following the standard procedure, the specimen of material was placed onto the 
surface of an inoculated agar plate (1 plate used per specimen) and weighed down 
with 200g cylinder for 60 s ± 5 s. Each specimen was then placed into a sterile petri 
dish with surface inoculated with bacteria uppermost using sterilised tweezers. 
For the touch transmission method, a sterile glove was worn by the operator and the 
fingers of the gloves were placed onto an inoculated agar plate and then the bacteria 
transferred onto the surface of the textile by placing the fingers on the surface of the 
material for 60 s ± 5 s. The inoculated sample was then transferred to a sterile petri 
dish transferred with the inoculated surface uppermost. 
 
For aerosol transmission, 2 ml aliquots of the inoculum were transferred into a glass 
bottle containing spray atomiser. Each spray was approximately 100-125 µl. 
The textile was placed onto the selective agar plate, then using the atomiser the 
textile was sprayed until evenly covered with inoculum, (approximately 6 sprays 
required). After allowing approximately 60 s ± 5 s for the aerosols to settle, the textile 
was transferred to sterile petri dish with inoculated surface uppermost,  
For incubation of all samples, a humidified chamber was recreated by soaking 
absorbant paper with sterile distilled water in the bottom of a sealable plastic box. 
The plates from the investigation were then placed into the box and incubated 
overnight (approx. 18h) at 37 oC.  
 
2.3.4 Recovery of bacteria from fabric samples  
  
Sterile stomacher bags were prepared, by aliquoting 20 ml of neutralising solution 
(as described in ISO20743) into each bag. The stomacher machine (Seward 
Stomacher 400C Lab Blender) was run using its standard setting on each side of the 





Calculation of bacterial concentration on each plate derived from ISO20743 
(ISO, 2013) 
 
Bacterial concentration of each plate can be determined using the following formula: 
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CB = bacteria concentration in cfu.ml-1 
Z is the average value of the two petri dishes in cfu.ml-1 
R is the dilution rate 
 
Number of bacteria calculations 
Bacteria can be enumerated using the following formula: 
 




M = the number of bacteria per specimen 
CB = bacteria concentration obtained  
 
Calculation of Antibacterial Activity: 
 
Antibacterial activity can be quantified using the following formula: 
R= Ut − At  
Where: 
R is the antibacterial activity. 
Ut is the average of the common logarithm of the number of viable bacteria, in cells 
cm-2, recovered from the untreated test specimens after 24 h. 
At is the average of the common logarithm of the number of viable bacteria, in cells 
cm-2, recovered from the treated test specimens after 24 h.  
For the parameter R to be within acceptable limits, successful the difference in log10 
values of cell number must be <2. 
3 Results: 
 
3.1 Experimental aim and design 
 
The purpose of this study was to understand the limitations of the ISO standards. 
The limitation identified involved an unrealistic challenge model for organisms in a 
clinical setting. Including how bacteria would encounter the untreated or treated 
textile. Therefore, through analysis of bacterial transmission in hospitals, the most 
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prevalent modes of transmission were identified as touch and aerosol transmission. 
Research into differing surfaces to simulate touch transmission included pig skin and 
latex gloves, however, using a sterilised latex glove was deemed the most 
appropriate and safe way to handle the bacteria and textile in this study. For aerosol 
transmission, nebulisers and atomiser spray bottles were the two considerations, 
resulting in the use of an atomiser, due to the study requiring more precision of the 
exact volume of liquid being placed onto the textile. Using a nebuliser would not 
have been a good challenge model for the textile, as a nebuliser does not simulate a 
sneeze or a faecal explosion. Therefore, an atomiser was chosen for the study, to 
ensure that the study was simulating human-like transmission onto the textile.  
 
Each organism was chosen for their difference in mode of transmission and location 
in the clinical setting in which they are found, and the concentration in which they are 
found. Additionally, each organism is ACDP level 2 and fast growing, meaning they 
are easier and safer to work with than more resistant strains which are ACDP 3. 
 
The results shown in Table 3 show that there is a reduction in the concentration of 
bacteria which is retrieved from treated textiles compared to untreated after the 
transfer method. However, this reduction in log10 viable count does not satisfy 
ISO20473 or ISO22196, with all organisms performing >2 log10 when the touch and 
aerosol transmission methods of inoculation were used.  
 
3.2 Challenge testing   
Throughout each sequential investigation, the standard ISO technique was 
performed as a control. 
 
To begin the study, each organism (Table 2.2) was used in a challenge test following 
the ‘transfer method’ of ISO20473 to begin the study to ensure results were in line 
with previous data. The standard procedure did show significant ‘antibacterial 
activity’ against both E. faecalis and S. aureus (Table 3A). This resulted in all plates 
for treated fabrics showing no growth on the plates after dilution, therefore 
antibacterial activity was quantified as <2 log10. However, P. aeruginosa consistently 
grew on both treated and untreated textiles (Appendix 2) showing insignificant 
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‘antibacterial activity’ against the organism. For Pseudomonas the highest difference 
in log10 was 0.42 and the lowest was 0.15.  
 
3.3 Challenge testing with added parameters 
 
3.3.1 Touch transmission 
 
The touch method was developed with the aim of simulating touch transmission and 
to add a realistic second tier parameter replicable to a clinical setting in the study. 
The touch method was developed by firstly touching the fabric with a glove but no 
organism to understand how the textile would be handled by healthcare workers, 
patients, or visitors. Next a test was carried out alongside a standard challenge test 
to trial the touch transmission. The results from this investigation showed that the 
methodology was sufficient and therefore this methodology was used throughout the 
investigations. The results consistently showed that with the addition of touch 
method onto the textiles, there was a significant reduction in the effectiveness of the 
treated and untreated textile. Including a difference of 0 in antibacterial activity 
between the treated and untreated textile for P. aeruginosa.  
 
3.3.2 Aerosol Transmission 
 
To develop aerosol transmission using the atomiser spray bottle, distilled water was 
sprayed onto the fabric to ensure an even coverage as a trial run. This trial run also 
allowed for timings for the aerosols to settle to be determined. After this trial the 
results were then used to then perform the experiments with bacteria instead of 
water. The results agreed with those gained using the touch inoculation, indicating 
that with the added parameters the ‘antibacterial activity’ of the treated and untreated 
textile were not notably different when the bacteria were deposited onto the surface 
this way. One anomalous result was gained using Enterococcus where there was no 
growth seen on the treated textile. Unfortunately, despite no growth of Enterococcus 
on the treated textile, there was still not sufficient log10 difference between the 
treated and untreated textile to deem the treated textile to be effective, illustrating a 
reduction in microbial load of 1.2 log10. However, E. faecalis also illustrated a 
negative difference, meaning that the untreated textile outperformed the treated 
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textile indicating that the antimicrobial embedded into the textile is least effective 
against E. faecalis.  
 
Table 3: Table of results to show antibacterial activity of specified strains 
including test including variations of standard method  
 
 













Untreated + Touch 13.6 272 0.434 
Treated + Touch 5 100 
Untreated +Aerosol 8.83 176 0.64 
Treated +Aerosol 2 40 
Untreated 36 720 2.857 













Untreated + Touch 24.6 493 0 
Treated + Touch 24.6 493 
Untreated +Aerosol 70.6 1413 0.44 
Treated +Aerosol 25.5 510 
Untreated 16.5 330 0.31 














Untreated + Touch 63.3 1266 0.027 
Treated + Touch 59.5 1190 
Untreated +Aerosol  26 520 -0.07 
Treated +Aerosol 30.8 616 
Untreated 14.3 286 2.46 
Treated 0 0 
 
 













Untreated + Touch 4.16 83 1.92 
Treated + Touch 0 0 
Untreated +Aerosol 37.5 750 0.91 
Treated +Aerosol 4.6 93 
Untreated 30 600 2.77 













Untreated + Touch 52 1040 0 
Treated + Touch 28.3 566 
Untreated +Aerosol 64 1280 0.41 
Treated +Aerosol 24.6 493 
Untreated 26.6 533 0.02 














Untreated + Touch 73 1460 0.19 
Treated + Touch 47 940 
Untreated +Aerosol  20 400 0.23 
Treated +Aerosol 11.8 236 
Untreated 28.3 566 2.75 
Treated 0 0 
 
 













Untreated + Touch 52 1040 0.25 
Treated + Touch 28.6 573 
Untreated +Aerosol 44.5 890 0.42 
Treated +Aerosol 17 340 
Untreated 41.3 826 2.92 













Untreated + Touch 68.3 1366 0.51 
Treated + Touch 20.8 416 
Untreated +Aerosol 24.5 490 0.17 
Treated +Aerosol 16.5 330 
Untreated 29.3 586 0.15 














Untreated + Touch 118 2360 3.37 
Treated + Touch 0 0 
Untreated +Aerosol  22.7 453 0.32 
Treated +Aerosol 10.8 216 
Untreated 62.6 1253 3.09 
Treated 0 0 
 
 
Table 1: Results of challenge tests, illustrating the comparative study between the 
treated and untreated textile for each test. Test 1, 2 and 3 are replicated of the same 
experiment. Untreated and treated represent the type of textile used and touch or 
aerosol represents the mode of transmission. Bacterial concentrations and 




4.1 Overview  
 
Using the standard ISO20743 ‘transfer method’ the results gained were as expected, 
indicating that the treated textile was successful in removing all bacteria for both S. 
aureus and E. faecalis. Conversely, the treated textile was unsuccessful in killing P. 
aeruginosa, however, the reasoning behind will be discussed below.  
The results given in Table 2.2 all illustrated a significant lack of ‘antibacterial activity’ 
and failed to produce the reduction of >2 log10 for all organisms when more realistic 
inoculation methods were used. This indicates that despite using the same 
concentration of bacteria, using realistic inoculation methods reduces the efficacy of 
the treated textile. Therefore, via analysis of ISO20473 standard (ISO, 2013), 
inoculating any surface with between 1x108 CFU ml-1 and 3x108 CFU ml-1of bacteria is 
not representative of a clinical setting. Consequently, with this large log drop, the 
expectation is that textiles which pass this test will outperform and kill the lower 
concentrations of bacterium found on the curtains in situ. The hypothesis that 
standard ISO testing would show that the treated materials worked for the most part 
was shown to be correct (Table 2.2). However, with the addition of simulated aerosol 
and touch transmission, all tested organisms showed significant growth, and 
therefore using these modes of inoculation the treated textile was found to have 
insignificant ‘antibacterial activity’.   
 
4.1.2 Staphylococcus aureus 
 
It has been reported in previous studies that silver nanoparticles have a significant 
effect on the growth of S. aureus (Li et al., 2011; Swolana et al., 2020). 
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As a bacterium that can normally reside harmlessly on the surface of human skin, 
Staphylococcus aureus has capacity to cause infection when the skin barrier is 
damaged via a cut or lesion and can also be inhaled nasally (Solberg, 2000). The 
two most common forms of transmission for these bacteria are touch and airborne. 
The results of the study are showed conclusively that there was a significant 
reduction in antibacterial activity effect when both touch and aerosol transmission 
was used. Despite this, the results from the study indicated that the treated textile 
had the most significant effect on aerosol transmission of S. aureus, compared to the 
effect seen on the other tested organisms.  
 
4.1.3 Enterococcus faecalis 
 
Enterococcus faecalis is an opportunistic pathogen typically found in the gut and 
bowel, therefore in a clinical scenario, diarrhoea or faecal matter in gastro-intestinal 
wards is where this is found. Therefore, the concentration used for inoculation 
(between 1x108CFU/ml and 3x108CFU/ml) as specified by the ISO20743 method, is 
more representative of levels expected to be found in faecal matter which contains 
incredibly high concentrations of these bacteria (Sghir et al., 2000). The primary 
mode of transmission for this organism is through the hands of healthcare workers 
(Weinstein and Hayden, 2000). Therefore, the results gained here which illustrate 
that E. faecalis has the lowest overall sensitivity to ‘antibacterial activity’ when the 
touch mode of transmission was used. Indicating that when touch transmission was 
used, E. faecalis had the most significant growth on the treated textile (Table 2.2A). 
However, under NHS and the Care Quality Commission (CQC) guidelines (NHS, 
2021; CQC, 2021), which Marlux Medical adhere to, the curtain should be taken 
down when visibly soiled. Unfortunately, unless in incredibly high concentrations, 
bacteria are not seen and therefore the treated textile must be able to inactivate 
bacteria at these high concentrations, as very small amounts of faeces can contain 
high levels of bacteria. 
 
4.1.4 Pseudomonas aeruginosa 
 
Potential reasoning behind the standard ISO technique showing unsuccessful 
‘antibacterial activity’ against Pseudomonas aeruginosa is due to this organism 
having natural mechanisms of silver resistance. Pseudomonas achieves this by 
producing the redox-active metabolite pyocyanin (Muller, 2018). Pyocyanin is 
produced by these bacteria to scavenge for iron when in the body, but the 
siderophore can also bind to other metal ions. A study by Muller and Merrett (2014) 
suggests a highly positive and significant correlation between pyocyanin production 
by P. aeruginosa and silver resistance. When stressed, Pseudomonas produces 
these green pigments and in this instance the silver ions on the fabrics appear to 
make Pseudomonas more stressed (see Appendix 2), the cells are upregulating their 
virulence genes and therefore become more virulent than when they were inoculated 
onto the untreated surface. However, there is literature supporting the effectiveness 
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of silver as an antimicrobial to Pseudomonas (Hwang et al., 2007; Bjarnsholt et al., 





4.2.1 Marlux Medical Curtains 
 
Using the ISO standards, the embedded curtain illustrated effective ‘antibacterial 
activity’ against both E. faecalis and S. aureus and confirm previous results that the 
textile will pass the ISO standard. However, this was not seen for P. aeruginosa. 
Therefore, further investigation is required to determine what antimicrobial would be 
more successful against P. aeruginosa. 
 
4.2.2 Suggestions  
 
To further the work described in this project, it is evident that making as more to 
realistic challenge model to simulate how bacteria would be typically encountering 
the textile is essential as the different modes of transmission used here strongly 
affected the results gained. Therefore, an additional type of touch transmission with 
skin-like material, for example sterile, irradiated pig skin, could be evaluated as a 
viable realistic challenge test for the textile (Leitgeb et al., 2013). In addition, running 
tests on the fabrics for longer durations of time would be beneficial to understanding 
if the treated textile requires longer periods of time to kill microorganisms. For 
hospitals which are implementing antimicrobial curtains, the use of different material 
and polymer on rotation could increase their overall efficacy to avoid the 
development of resistant populations. Antimicrobial resistance is a constant battle, 
with the ‘race’ against bacterial resistance becoming ever more difficult. By 
introducing different antimicrobials on a rotational basis this would ensure any 
bacteria that are becoming resistant are not feeding back into the hospital’s 
population. One concern raised in this study is that the antimicrobial activity was not 
equally effective against different types of bacteria typically found in different wards 
of hospitals. Therefore, a key aspect of the study would be to challenge test different 
samples of an untreated curtain from each ward of the hospitals. This test would 
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ensure that upon rotation, the different polymer curtain could be placed into the ward 
depending on which bacteria are most likely to predominate in that specific ward. 
Parallel to this study, polymer research is essential for different strains of bacteria. 
Specifically, it has been shown that the size and shape of nanoparticles has a drastic 
effect on their efficacy (Sun et al., 2018). Therefore, understanding the size and 
shape of the silver nanoparticles which are being embedded into the curtains could 
be optimised to increase antimicrobial activity on the textile. Research into different 
metal ions effectiveness could result in a successful rotational curtain business. With 
different ions and compounds, also comes the possibility of using different 
concentrations. Perhaps in wards such as ICU an increased concentration of the 
antimicrobial may be required to help reduce the risk of transmission between 
severely ill patients.  
Finally, research into resistant strains of bacteria is required and must be 
incorporated into polymer development, which is also the link behind the reasoning 
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Appendix 1.1 + 1.2 : Visual depiction of bacterial growth from ISO20473 transfer 
method for S. aureus and E. faecalis on treated versus untreated textile.  
 
Appendix 1.1, Photographic display of untreated medical fabric conveying growth on 











 Appendix 1.2, Photographic display of treated medical fabric conveying no growth 













Appendix 2.1 + 2.2: Visual depictions of Pseudomonas after ISO transfer method 2.1 
Untreated sample of Pseudomonas after transfer method, 2.2 Treated sample of 
Pseudomonas after transfer method 
 
 Appendix 2.1: Pseudomonas showing growth on untreated fabric following transfer 











Appendix 2.2: Pseudomonas showing growth on treated fabric following transfer 
method derived from ISO20743. 
 
 
 
 
 
 
 
 
 
 
